Stevens-Johnson Syndrome: Clinical Trials

2 unknown. 2 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

Phase	Trials	Status
Phase 2	2	Unknown 2
Phase 1	1	Unknown 1
Phase 3	1	Unknown 1

Follow Stevens-Johnson Syndrome: new trials by email Literature Review of Stevens-Johnson Syndrome trials Research Report on Stevens-Johnson Syndrome

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Clinical Trial to Evaluate Safety and Efficacy of Cell Therapy in Patients With Cicatricial Conjuntivitis. Single Dose, Double Dose - Chronic Conjunctivitis, Stevens-Johnson Syndrome	Phase 1 / Phase 2	Unknown	Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz	20	2022-11-11	2024-07-08
Severe Bullous Drug Eruption and Filgrastim Filgrastim, Placebo - Rare Diseases, Toxic Epidermal Necrolyses	Phase 2 / Phase 3	Unknown	Hospices Civils de Lyon	42	2022-05-13	2024-05-08

Narrower conditions

Pemphigoid, Bullous (1)  ·  Rare Diseases (1)

Broader conditions

Chemically-Induced Disorders (2)  ·  Dermatitis (2)  ·  Drug Eruptions (2)  ·  Drug Hypersensitivity (2)  ·  Drug-Related Side Effects and Adverse Reactions (2)  ·  Erythema (2)  ·  Erythema Multiforme (2)  ·  Hypersensitivity (2)  ·  Hypersensitivity, Delayed (2)  ·  Immune System Diseases (2)  ·  Mouth Diseases (2)  ·  Skin Diseases (2)  ·  Skin Diseases, Vesiculobullous (2)  ·  Skin and Connective Tissue Diseases (2)  ·  Stomatitis (2)

Interventions

Filgrastim (1)

Sponsors

Hospices Civils de Lyon (1)  ·  Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz (1)

Countries

France (1)  ·  Spain (1)